(Q42800460)

7 November 2017

Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo (English)

1 reference

7 November 2017

Rowell CA

1

1 reference

7 November 2017

Kowalczyk JJ

series ordinal

2

1 reference

7 November 2017

Lewis MD

series ordinal

3

1 reference

7 November 2017

Garcia AM

series ordinal

4

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

Journal of Biological Chemistry

7 November 2017

1 reference

7 November 2017

272

1 reference

7 November 2017

14093-14097

1 reference

7 November 2017

22

1 reference

p21ras is modified by a farnesyl isoprenoid

7 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

All ras proteins are polyisoprenylated but only some are palmitoylated

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Farnesyl transferase inhibitors: the successes and surprises of a new class of potential cancer chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Enzymatic modification of proteins with a geranylgeranyl isoprenoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Identification of geranylgeranyl-modified proteins in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Resistance of K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14093

21 January 2018

Identifiers

DOI

10.1074/JBC.272.22.14093

1 reference

7 November 2017

1 reference